TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Ultrasound patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician's diagnostic impression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of cases of laboratory-confirmed malaria
Endpoint domain: Adverse events/effects
Primary endpoint: Ophthalmic and systemic TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Central Nervous System Disease Control Rate (DCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: maximum range of motion of bilateral diaphragm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change rate of diaphragm thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reproducibility of the IOI-HA and COSI questionnaires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal consistency of the IOI-HA and COSI questionnaires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discriminatory performance of the IOI-HA and COSI questionnaires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-hour pad test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of SCFAs in fecal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quantification of whole-body lean mass with DXA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of hand grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of life as assessed by the Saint George's Respiratory Questionnaire-C (SGRQ-C)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: DN4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of HOXB13 c.853delT mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Generalization Performance on the Concurrent Discrimination and Transfer Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalization Performance on the Acquired Equivalence Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medial Temporal Lobe Neural Flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of unnecessary antibiotic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Change in hallucinations/delusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Development of right ventricular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Physical Function subscale of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of potentially inappropriate medication prescription
Endpoint domain: Adverse events/effects
Primary endpoint: Carotid body function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Berg balance scale (BDO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-minute walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saint George Respiratory Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Medical Research Council scale (MMRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frail fragility scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Days free from invasive mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 30 Day All-Cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Disease severity assessment using DAS-28 -CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut microbiota composition variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of pneumococcal carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Serotype distribution of pneumococcal strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cumulative fluid balance on day 3 in ml/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-metre walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appendicular skeletal muscle mass (ASM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Balancing ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in msSBP (Systolic Blood Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent change from baseline in LDL-C (Low-Density Lipoprotein Cholesterol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in general self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of chronic kidney diseases in non-CKD participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Progression of chronic kidney diseases in CKD participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean H-reflex Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean PRM Reflex Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage change in HVPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Self Rated Abilities for Health Practice (SRAHP)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major adverse limb event (MALE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in SIGH-SAD total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Phase angle difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIN2+ recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Avacopan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) from Time Zero to Time of Last Quantifiable Concentration (AUClast) of Avacopan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HD Clearance of Drug From Plasma (CLD) of Avacopan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients completing at least 3 cycles of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cigarette Smoking Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of household child contacts initiated on TB preventive therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants with venous thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Proportion of SCD patients with preserved anti-HBs response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of SCD patients with HBV-specific cellular response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical sensitivity and specificity of antigen tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal brain perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neonatal brain peak enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neonatal brain perfusion time to peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neonatal brain perfusion volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adherence to Heart-Health Preventive Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Accuracy of Cardioflux diagnosis/screening of ACS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants experiencing any treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change from Baseline in monthly countable seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of participants free from episodes of prolonged seizures and/or status epilepticus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of women with pathological placental findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Agitation Management Self-efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Revised Interpersonal Reactivity Index (R-IRI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rate for the correct identification of the cricoid cartilage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular DCNVA (distance corrected near visual acuity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Warwick-Edinburgh Mental Well-Being Scale (WEMBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subject incidence of adverse events for XZP-5610 versus placebo
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement on the XeQoL questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Failure or rejection of transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Post-operative -non-infectious complications improvement
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative -infectious complications improvement
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative improvement days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall Effectiveness Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KT-1000
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease rate of CA19-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: hip joint patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensitivity of vHIT device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of vHIT device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss during operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent in PACU (recovery room)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of opioid pain medications required to control postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and duration of seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Changes in EEG and qEEG results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients receiving a second parenteral pain medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change-from-baseline in circulating LDL-cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of adverse events (AEs) reported for 30 days after receipt of any study product
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Serious Adverse Reactions (SAEs) leading to early participant withdrawal or permanent discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of serum IgG binding antibodies to vaccine-matched HIV-1 Env trimers and specific epitopes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average Urticaria Control Test (UCT) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Zero to Time t (AUC[0-t]) of Tirzepatide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Zero to Infinity (AUC[0-∞]) of Tirzepatide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cellular immunity against T. gondii
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severity of exercise beliefs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of sports anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of mental toughness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of coping effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum tolerated dose (MTD) of oral HMPL-295S1
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended phase II clinical study dose (RP2D) of oral HMPL-295S1
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 24-Hour Mean Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of non-medical opioid use behaviors
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic yield of capsule-sponge for detecting ESCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant Safety - vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant Safety - clinical lab values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days without SIRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time above 90% VO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back height difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of hypertension to below 130/80 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sustained improvement of blood pressure below 130/80 mmHg at 3-6 month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Testosterone suppression at castrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: circulating levels of follistatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of incapacity derived from neck pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Activation patterns of scapular muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Treatment Intensification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Echocardiography- LVEF (Left Ventricular Ejection Fraction) in percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Threshold concentrations for ragweed and birch pollen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ex-vivo plasma cholesterol efflux capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Expression of ABCA1 and ABCG1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants achieving clinical symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Walking Pain 0-10 NRS
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in mean distance control scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening of diabetic retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Resistance to adherence to vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of microbial profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge improvement regarding NCDs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attitude improvement regarding NCDs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Practice improvement regarding NCDs
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Urinary incontinence severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrence of Streptococcus pyogenes pharyngotonsillitis infection
Endpoint domain: Adverse events/effects
Primary endpoint: Probiotic safety and tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: accuracy of change PVI in detecting volume responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Macular Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Time to device being fitted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to treatment decision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: D-QUEST
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CSD-OPUS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of SARS-CoV-2 RNA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Atrial Flutter or Supraventricular Tachycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity of metastatic lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median maximum standardized uptake value (SUVmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Standardized Uptake Value averaged across lesions (SUVmax-avg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative dose of opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood test values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal oxygen uptake test (VO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on blood biochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient understanding of primary diagnosis of hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Reported Outcomes (Quality of Life/Fatigue/Physical Function)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to first occurrence of Stroke or systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: HbA1c (A1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetes Distress Scale-17 (DDS-17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percentage of patients in low risk for disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Intensive care unit (ITU) stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Postoperative overall length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: target-specific extracellular vesicle release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum walking distance (MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain free walking distance (PFWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: claudication score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in affective social support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Interest in using herbs and spices in cooking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of using herbs and spices in cooking
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Confidence in using herbs and spices in cooking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intestinal indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: RT-PCR confirmed symptomatic COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Cervical Joint Range of Movement Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes